| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |